Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Clin Pharmacol Ther. 2014 Mar 17;96(2):175–181. doi: 10.1038/clpt.2014.62

Table 3.

Changes from baseline in heart rate (HR), systolic blood pressure (SBP), & diastolic blood pressure (DBP) in poor (PM), intermediate (IM), extensive (EM) and ultrarapid (UM) metabolizers of CYP2D6 treated with metoprolol

Parameter PM IM EM UM P

Change in HR (beats/min) −16.6± 6.9 − 18.6± 5.1 −11.4± 6.6 −11.2± 8.2 0.0001
Change in SBP (mm Hg) −9.4± 9.0 −6.5± 11.1 −7.1± 9.8 −9.4± 5.1 0.91
Change in DBP (mm Hg) −9.3± 5.1 −8.3± 7.5 −7.0± 6.6 −7.5± 4.8 0.37